Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Drugs Aging. 2010 Jun 1;27(6):457–470. doi: 10.2165/11536260-000000000-00000

Table 1.

Characteristics of RBD in large case series

Schenck 1993[9] Sforza 1997[12] Olson 2000[8] Wing 2008[125]
Number of patients 96 52 93 82
% male 87.5% -- 87% 82%
Mean (SD) age of onset 52.4 (16.9) Duration of disease prior to diagnosis: 4.3 (0.9) in idiopathic;
4.9(0.6) with secondary forms
60.9 (36–84) 62.1 (12.9)
Mean (SD) age at diagnosis 58.3 (17.4) 66.2 (2.1) for idiopathic form;
59.9 (1.2) for those associated with neurologic disease
64.4 (37–85) 67.4 (10.0)
Percent with a history of sleep-related injury 79.2% 32% (injury to self)
16% injury to bedpartner)
80.8%
Percent with sleep disruption 20.8% Some degree of sleep disruption present in 100%.
Average (SD) sleep efficiency 66.4 (4.4) in idiopathic RBD, 52.4 (2.6) in secondary
70% (self report) --
Frequency of dream enacting behaviors 87.5% 93% 98%
Comorbid neurologic diagnoses 47.9% (composed of degenerative disorders in 23%, narcolepsy in 14%, other in 11%) 75% 57% (47% PD, 13% dementia, 26% MSA, 8% narcolepsy, 2% PSP, 2% brainstem stroke) 19.5%
Comorbid or lifetime history of psychiatric disorders 9.4% -- 25.8% (lifetime history) 33% (lifetime history)
Response to clonazepam Total 90.0% (79.1% complete, 11.1% partial) 90% 87% (of the 38 people for whom information was available);
55% complete, 32% partial
87% of 71 pts